Kopfgrafik

SHOP: EGF Receptor erbB,Blocking Peptides

back Back to List

Blocking Peptide phospho-EGFR, pTyr 845

Order No. Size sufficient for Price
2003-100/EGFR-pTyr845   208,00  €
Order No.: 2003-100/EGFR-pTyr845
Description:
Specificity: Blocking Peptide for monoclonal antibody EGFR-12A3
Size sufficient for:  
Formulation: lyophilized
Applications: Blocking of mab EGFR-12A3 (pTyr 845)
Price: 208,00 €
References: Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer. Hudelist G, Köstler J, Czerwenka K, Kubista E, Attems J, Müller R, Gschwantler-Kaulich D, Manavi M, Huber I, Hoschützky H, Zielinski CC, Singer CF. Int. J. Cancer: 118, 1126-1134 (2006)
Blocking Peptide for monoclonal antibody EGFR-12A32003-100/EGFR-pTyr845Blocking Peptide for monoclonal antibody EGFR-12A3
Order No. Clone Name Specificity
2004-100/EGFR-pTyr1045 2004-100/EGFR-pTyr1045 Control phosphopeptide for monoclonal antibody EGFR-11C2 against phospho-EGFR (pTyr 1045)
2005-100/EGFR-pTyr1068 2005-100/EGFR-pTyr1068 Control phosphopeptide for monoclonal antibody EGFR-15A2 against phospho-EGFR (pTyr 1068)
2007-100/EGFR-pTyr1148 2007-100/EGFR-pTyr1148 Control phosphopeptide for monoclonal antibody EGFR-10G12 against phospho-EGFR (pTyr 1148)
2006-100/EGFR-pTyr1173 2006-100/EGFR-pTyr1173 Control phosphopeptide for monoclonal antibody EGFR-9H2 against phospho-EGFR (pTyr 1173)
2009-100/erbB2-pTyr877 2009-100/erbB2-pTyr877 Control phosphopeptide
2010-100/erbB2-pTyr1139 2010-100/erbB2-pTyr1139 Control phosphopeptide
2008-100/erbB2-pTyr1248 2008-100/erbB2-pTyr1248 Control phosphopeptide for monoclonal antibody erbB2-6G7 against phospho-erbB2 (pTyr 1248)
2011-100/erbB4-pTyr1188 2011-100/erbB4-pTyr1188 Control phosphopeptide